Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

RSLS Insider Trading (ReShape Lifesciences)

Insider Ownership Percentage: 8.10%
Insider Buying (Last 12 Months): $158,550.00
Insider Selling (Last 12 Months): $1,776,199.35

ReShape Lifesciences Insider Trading History Chart

This chart shows the insider buying and selling history at ReShape Lifesciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ReShape Lifesciences Share Price & Price History

Current Price: $0.56
Price Change: Price Decrease of -0.02 (-3.45%)
As of 07/1/2022 01:00 AM ET

This chart shows the closing price history over time for RSLS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

ReShape Lifesciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/1/2022Barton P. BandyCEOSell11,309$0.95$10,743.55796,214View SEC Filing Icon  
5/31/2022Thomas StankovichCFOBuy20,000$0.92$18,400.00365,627View SEC Filing Icon  
4/1/2022Barton P. BandyCEOSell11,063$1.13$12,501.19818,940View SEC Filing Icon  
4/1/2022Thomas StankovichCFOSell5,038$1.13$5,692.94350,156View SEC Filing Icon  
1/31/2022Barton P. BandyCEOSell8,324$1.22$10,155.28View SEC Filing Icon  
1/31/2022Thomas StankovichCFOSell3,684$1.22$4,494.48View SEC Filing Icon  
1/4/2022Barton P. BandyCEOSell7,150$1.79$12,798.50View SEC Filing Icon  
1/4/2022Thomas StankovichCFOSell3,171$1.78$5,644.38View SEC Filing Icon  
12/2/2021Barton P. BandyCEOSell13,427$1.83$24,571.41View SEC Filing Icon  
12/2/2021Thomas StankovichCFOSell4,304$1.83$7,876.32View SEC Filing Icon  
11/18/2021Thomas StankovichCFOBuy20,000$2.02$40,400.00View SEC Filing Icon  
11/2/2021Barton P. BandyCEOSell13,505$2.69$36,328.45View SEC Filing Icon  
11/2/2021Thomas StankovichCFOSell4,320$2.69$11,620.80View SEC Filing Icon  
10/1/2021Barton P. BandyCEOSell12,565$2.77$34,805.05View SEC Filing Icon  
10/1/2021Thomas StankovichCFOSell3,660$2.76$10,101.60View SEC Filing Icon  
9/10/2021Barton P. BandyCEOSell294,494$2.89$851,087.66960,100View SEC Filing Icon  
9/10/2021Dan W. GladneyDirectorSell200,000$2.99$598,000.00View SEC Filing Icon  
9/10/2021Thomas StankovichCFOSell48,366$2.89$139,777.74315,995View SEC Filing Icon  
8/30/2021Thomas StankovichCFOBuy15,000$3.43$51,450.0032,613View SEC Filing Icon  
8/20/2021Thomas StankovichCFOBuy15,000$3.22$48,300.0017,613View SEC Filing Icon  
12/4/2020Armistice Capital Master FundMajor ShareholderBuy6,400$4.16$26,624.00
9/22/2020Armistice Capital Master FundMajor ShareholderBuy3,300$4.13$13,629.00
8/20/2020Armistice Capital Master FundMajor ShareholderBuy9,998$3.13$31,293.74
1/29/2020Armistice Capital Master FundMajor ShareholderBuy3,000$8.00$24,000.00
12/20/2019Armistice Capital Master FundMajor ShareholderBuy12,048$5.00$60,240.00
12/16/2019Armistice Capital Master FundMajor ShareholderBuy3,000$5.50$16,500.00
12/11/2019Armistice Capital Master FundMajor ShareholderBuy2,523$5.45$13,750.35
9/17/2019Armistice Capital Master FundMajor ShareholderBuy396,072$0.05$19,803.60
8/29/2019Armistice Capital Master FundMajor ShareholderBuy200,000$0.07$14,000.00View SEC Filing Icon  
8/8/2019Armistice Capital Master FundMajor ShareholderBuy350,000$0.07$24,500.00View SEC Filing Icon  
7/26/2019Armistice Capital Master FundMajor ShareholderBuy500,000$0.08$40,000.00View SEC Filing Icon  
See Full Table
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

SEC Filings (Institutional Ownership Changes) for ReShape Lifesciences (OTCMKTS:RSLS)

16.86% of ReShape Lifesciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RSLS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

ReShape Lifesciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/11/2022GSA Capital Partners LLP36,490$43K0.0%N/A0.196%Search for SEC Filing on Google Icon
11/15/2021Sassicaia Capital Advisers LLC10,000$29K0.1%N/A0.063%Search for SEC Filing on Google Icon
8/17/2021Armistice Capital LLC816,527$4.08M0.1%N/A24.447%Search for SEC Filing on Google Icon
8/16/2021State Street Corp109,999$0.55M0.0%N/A3.293%Search for SEC Filing on Google Icon
8/13/2021Alpine Global Management LLC17,000$85K0.0%N/A0.509%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC23,277$0.12M0.0%N/A0.697%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.51,120$0.26M0.0%N/A1.531%Search for SEC Filing on Google Icon
11/13/2018Renaissance Technologies LLC2,287,729$0.10M0.0%N/A3,812.882%Search for SEC Filing on Google Icon
8/13/2018International Biotechnology Trust PLC52,546$0.12M0.0%-93.3%0.824%Search for SEC Filing on Google Icon
2/15/2018Anson Funds Management LP219,016$0.32M0.2%N/A0.731%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
ReShape Lifesciences logo
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.
Read More on ReShape Lifesciences

Today's Range

Now: $0.56
Low: $0.55
High: $0.58

50 Day Range

MA: $0.76
Low: $0.56
High: $1.01

52 Week Range

Now: $0.56
Low: $0.55
High: $6.25

Volume

93,070 shs

Average Volume

192,527 shs

Market Capitalization

$10.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of ReShape Lifesciences?

ReShape Lifesciences' top insider shareholders include:
  1. Barton P Bandy (CEO)
  2. Barton P Bandy (CEO)
  3. Thomas Stankovich (CFO)
  4. Armistice Capital Master Fund (Major Shareholder)
  5. Armistice Capital, Llc (Major Shareholder)
  6. Dan W Gladney (Director)
Learn More about top insider investors at ReShape Lifesciences.
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.